Atlas Trials

Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy

Clinical trial NCT02332447 · COMPLETED

Trial details

NCT number
NCT02332447
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Epilepsy
Start date
2015-06-26
Primary completion
2020-07-30
Enrollment
485

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.